Program Overview
Please read the following program information before accessing the presentations using links located at the bottom of this page
Release date: June 1, 2008 Expiration Date: May 31, 2009
Continuing Education Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program provides 1.5 hours (0.15 CEUs) of continuing education credit (program number 204-000-08-414-H01P).
Methods/Format
This is an online activity consisting of audio, presentation slides, post-test, and activity evaluation tool. Participants must view the entire presentation, take the activity post-test, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time required to complete this activity is 1.5 hours. This activity is provided free of charge.
Target Audience
This continuing education program was planned to meet the needs of pharmacists, especially those involved in the management of patients with acute coronary syndrome.
Activity Content
Click here to view an overview of the activity content.
Learning Objectives
After participating in this educational activity, participants should be able to
- Describe the clinical and economic burden, pathophysiology, and patient presentation of ACS.
- Compare and contrast the pharmacologic effects and role of various anticoagulant agents in patients with ACS.
- Explain the rationale for ACC/AHA guidelines for anticoagulant therapy in patients with NSTE ACS or STEMI based on the results of key clinical trials.
- Discuss the role of evidence-based guidelines in performance measurement to improve the quality of care provided to patients with ACS.
Faculty
Paul P. Dobesh, Pharm.D., FCCP, BCPS (AQ Cardiology)
Associate Professor of Pharmacy Practice
College of Pharmacy
University of Nebraska Medical Center
Omaha, Nebraska
Disclosure Statements
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.
The faculty and planners report the following relationships:
Paul P. Dobesh, Pharm.D., FCCP, BCPS (AQ Cardiology)
Dr. Dobesh declares that he has served as a consultant for The Medicines Company and Eli Lilly and Company, and on the speaker’s bureau for sanofi-aventis.
Sarah A. Spinler, Pharm.D., FCCP, BCPS (AQ Cardiology)
Dr. Spinler reports that she has served on the speaker’s bureau for GlaxoSmithKline and sanofi-aventis. She also reports that she has served as a consultant for sanofi-aventis and The Medicines Company.
Kristi N. Hofer, Pharm.D.
Dr. Hofer declares that she has no relationships pertinent to this activity.
This activity is supported by an educational grant from sanofi-aventis U.S.
Launch Presentation
Applying ACC/AHA Guidelines to Anticoagulant Therapy in the Management of Acute Coronary SyndromePresented by Paul P. Dobesh, Pharm.D., FCCP, BCPS (AQ Cardiology)
Download Post-Test
Click here to print the post-test for your reference. Please note that to be eligible for continuing education credit, you must go to the ASHP Advantage CE Testing Center and complete the test online.
